Ioannis Parodis (@ioannisparodis) 's Twitter Profile
Ioannis Parodis

@ioannisparodis

MD PhD | Associate Professor of #Rheumatology @KarolinskaInst with interest in #lupus and #autoimmunity

ID: 867096608

linkhttps://parodislab.com calendar_today07-10-2012 23:09:12

1,1K Tweet

1,1K Followers

1,1K Following

Andreas Kronbichler (@akronbichler) 's Twitter Profile Photo

It is of importance to us to understand the habits of physicians to use anticoagulation in nephrotic syndrome. Please spend 5 minutes to answer some pressing questions including the potential role or aspirin! The Link is posted below: qualtricsxm564785h8t.qualtrics.com/jfe/form/SV_7O…

Lupus Research (@lupusresearch) 's Twitter Profile Photo

The LRA is delighted to share a message from the NYC Mayor Eric Adams recognizing #LupusAwarenessMonth during the month of May. ✨

The LRA is delighted to share a message from the NYC Mayor Eric Adams recognizing #LupusAwarenessMonth during the month of May. ✨
Lupus 2025 (@lupuscongress) 's Twitter Profile Photo

Join Sasha Bernatsky at #LUPUS2025 in Toronto, 21-24 May! 💡 Discover the latest research and connect with experts shaping the future of lupus care. Save your spot now! 🔗 bit.ly/42X1ZvH #Lupus #LupusResearch #Rheumatology

Lupus Hub (@lupus_hub) 's Twitter Profile Photo

📝 A new set of consensus recommendations published in Autoimmunity Reviews emphasize early remission, regular monitoring, and individualized treatment for #SLE. More news: lupushub.com Matteo Piga Manuel Ugarte-Gil Ioannis Parodis Laurent ARNAUD #Lupus #MedNews #MedEd

📝 A new set of consensus recommendations published in Autoimmunity Reviews emphasize early remission, regular monitoring, and individualized treatment for #SLE.

More news: lupushub.com 

<a href="/RMD_clinic/">Matteo Piga</a> <a href="/mugartegil/">Manuel Ugarte-Gil</a> <a href="/IoannisParodis/">Ioannis Parodis</a> <a href="/Lupusreference/">Laurent ARNAUD</a> 
#Lupus #MedNews #MedEd
3TR-IMI (@3tr_imi) 's Twitter Profile Photo

🎙 On #WorldAsthmaDay, #3TR patient representative Theo Schilpzand, who lives with severe #asthma, shares his perspective on how Patient Reported Outcomes (PROs) are key to developing treatments that truly meet patient needs. ▶️ Watch the full video here: 3tr-imi.eu/research/patie…

Lupus Research (@lupusresearch) 's Twitter Profile Photo

🧬✨ May is #LupusAwarenessMonth, a time to shine a light on #lupus! Share this post to spread awareness on common symptoms of lupus. LupusResearch.org

🧬✨ May is #LupusAwarenessMonth, a time to shine a light on #lupus! Share this post to spread awareness on common symptoms of lupus. 
LupusResearch.org
ACR_Journals (@acr_journals) 's Twitter Profile Photo

Now published simultaneously in AC&R + A&R, the 2024 ACR Guideline for the Screening, Treatment, and Management of Lupus Nephritis See ACR guideline page for resources - rheumatology.org/lupus-guideline DOI link - doi.org/10.1002/acr.25… Download the article - acr.tw/44sRwJM

Now published simultaneously in AC&amp;R + A&amp;R, the 2024 ACR Guideline for the Screening, Treatment, and Management of Lupus Nephritis

See ACR guideline page for resources - rheumatology.org/lupus-guideline

DOI link - doi.org/10.1002/acr.25…

Download the article - acr.tw/44sRwJM
Lupus 2025 (@lupuscongress) 's Twitter Profile Photo

Just 2 weeks until #LUPUS2025 begins! ⏳ Get ready for groundbreaking sessions and networking in Toronto from May 21-24, 2025. ✅ Register now: bit.ly/3EpftXR #LupusResearch #Rheumatology #MedicalEvents

Just 2 weeks until #LUPUS2025 begins! ⏳
Get ready for groundbreaking sessions and networking in Toronto from May 21-24, 2025. 
✅ Register now: bit.ly/3EpftXR

#LupusResearch #Rheumatology #MedicalEvents
RMD Open (@bmj_rmdopen) 's Twitter Profile Photo

🦋 Belimumab in #SLE: post-hoc of 5 phase III RCTs (n = 3 086) 📌 BICLA response at 52 wks vs placebo: OR 1.47 ✅ SLEDAI-2K ≥ 10: OR 1.67 ✅ anti-dsDNA +/low C3/C4: OR 1.54 ✅ Concomitant anti-malarials boost response 46 % vs 31 % (placebo w/o AMA) ↪️ Works even if GC >

🦋 Belimumab in #SLE: post-hoc of 5 phase III RCTs (n = 3 086)

📌 BICLA response at 52 wks vs placebo: OR 1.47
✅ SLEDAI-2K ≥ 10: OR 1.67

✅ anti-dsDNA +/low C3/C4: OR 1.54

✅ Concomitant anti-malarials boost response 46 % vs 31 % (placebo w/o AMA)

↪️ Works even if GC &gt;
Chris Wincup (@chriswincup) 's Twitter Profile Photo

It was an absolute pleasure to help shape the BSR British Society for Rheumatology Spotlight on Immunology! 🧫 A wonderful opportunity to speak with brilliant colleagues & discuss amazing science Check out the podcast on #lupus immunology with Prof Mariele Gatto

It was an absolute pleasure to help shape the <a href="/RheumatologyUK/">BSR</a> British Society for Rheumatology Spotlight on Immunology! 🧫 

A wonderful opportunity to speak with brilliant colleagues &amp; discuss amazing science

Check out the podcast on #lupus immunology with Prof Mariele Gatto
Rheumatology & Rheumatology Advances in Practice (@rheumjnl) 's Twitter Profile Photo

Ioannis Parodis Jasvinder A Singh et al. investigate the barriers to and facilitators of sustaining a decision aid tool for SLE patients in USA rheumatology outpatient care. 👉bit.ly/3YyKmjl 👉User-friendly design and DA effectiveness for decision-making are key facilitators.

Autoinmunes Medicina Interna Parc Taulí (@autoinmi_tauli) 's Twitter Profile Photo

International lupus day🦋 Consensus recommendations for the implementation of treat-to-target strategies ⏩ start treatment early, aim for remission, involve patients, use digital tools. ⏩ taper steroids to ≤5 mg/day. ⏩Tailored plans are key. doi.org/10.1016/j.autr…

International lupus day🦋

Consensus recommendations for the implementation of treat-to-target strategies

⏩ start treatment early, aim for remission, involve patients, use digital tools.

⏩ taper steroids to ≤5 mg/day.

⏩Tailored plans are key.

doi.org/10.1016/j.autr…
3TR-IMI (@3tr_imi) 's Twitter Profile Photo

#Lupus affects millions but is often misunderstood. On #WorldLupusDay, #3TR unites to #MakeLupusVisible. Blanca Rubio, Lupus Europe patient representative, discusses how #PROs can transform care and improve treatment. 👉 Watch: 3tr-imi.eu/research/patie…

SLEuro (@sleurosociety) 's Twitter Profile Photo

On May 10th, we come together to recognize and show support for those affected by SLE. Join our activities to get more involved in the care of this complex autoimmune disease. Discover more: sleuro.org Become a member for free here: sleuro.org/membership/

On May 10th, we come together to recognize and show support for those affected by SLE.
Join our activities to get more involved in the care of this complex autoimmune disease.
Discover more: sleuro.org

Become a member  for free here:
sleuro.org/membership/
Lupus Research (@lupusresearch) 's Twitter Profile Photo

💜 Today is #WorldLupusDay! Let’s take time today to shine a light on #lupus, honor every lupus champion, and celebrate all who are making a difference. We stand together! You are not alone. #ManyOneCan get involved in advancing #lupusresearch: bit.ly/ManyOneCan2025

💜 Today is #WorldLupusDay! Let’s take time today to shine a light on #lupus, honor every lupus champion, and celebrate all who are making a difference. We stand together! You are not alone.

#ManyOneCan get involved in advancing #lupusresearch: bit.ly/ManyOneCan2025